New combo aims to shield brain from powerful cancer Treatment's harsh side effects
NCT ID NCT04514029
Summary
This early-stage study is testing whether giving two existing drugs—dexamethasone (into the spine) and simvastatin (a pill)—can safely prevent or reduce serious brain-related side effects in adults with lymphoma receiving a powerful treatment called CAR-T cell therapy. The main goal is to see if it's practical for patients to complete this added treatment plan. Researchers will also check if it lowers the rate of these neurological complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.